Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$150M |
| 2 |
ExxonMobil
XOM
|
+$121M |
| 3 |
Visa
V
|
+$94.9M |
| 4 |
Columbia Banking Systems
COLB
|
+$94.4M |
| 5 |
GE HealthCare
GEHC
|
+$89.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$320M |
| 2 |
JPMorgan Chase
JPM
|
+$209M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$96.7M |
| 4 |
GE Aerospace
GE
|
+$89M |
| 5 |
ConocoPhillips
COP
|
+$88.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.82% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.26% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Vor Biopharma
VOR
$1.14B
| $231K | ﹤0.01% |
2,144
+70
| +3% | +$7.76K |
|
3177
Latham Group
SWIM
$627M
| $231K | ﹤0.01% |
80,750
+46,232
| +134% | +$162K |
|
|
CZOO
3178
DELISTED
Cazoo Group Ltd
CZOO
| $228K | ﹤0.01% |
924
-5
| -0.5% | -$1.63K |
|
3179
First US Bancshares
FUSB
$92.2M
| $227K | ﹤0.01% |
30,297
| – | – |
|
|
ZYXI
3180
DELISTED
Zynex
ZYXI
| $226K | ﹤0.01% |
18,844
+946
| +5% | +$12.4K |
|
3181
Annexon
ANNX
$836M
| $225K | ﹤0.01% |
58,526
+1,370
| +2% | +$7.54K |
|
3182
US Global Investors
GROW
$35.5M
| $225K | ﹤0.01% |
85,107
+796
| +0.9% | +$2.3K |
|
3183
Natural Health Trends
NHTC
$14.9M
| $222K | ﹤0.01% |
44,882
-2,323
| -5% | -$11.5K |
|
|
MRNS
3184
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $221K | ﹤0.01% |
32,089
| – | – |
|
|
OKUR
3185
OnKure Therapeutics
OKUR
$155M
| $221K | ﹤0.01% |
3,702
+1,747
| +89% | +$63.3K |
|
|
SOHO
3186
DELISTED
Sotherly Hotels
SOHO
| $219K | ﹤0.01% |
109,659
| – | – |
|
3187
Enliven Therapeutics
ELVN
$3.96B
| $217K | ﹤0.01% |
9,915
+942
| +10% | +$19.2K |
|
3188
Neonode
NEON
$14.2M
| $216K | ﹤0.01% |
28,402
| – | – |
|
3189
Dominari Holdings
DOMH
$55.4M
| $215K | ﹤0.01% |
66,675
| – | – |
|
3190
Heritage Global
HGBL
$40.3M
| $208K | ﹤0.01% |
72,332
+24,452
| +51% | +$64.6K |
|
|
CALB
3191
DELISTED
California BanCorp Common Stock
CALB
| $207K | ﹤0.01% |
+10,621
| New | +$251K |
|
3192
AGNC Investment
AGNC
$12.4B
| $207K | ﹤0.01% |
+20,522
| New | +$223K |
|
3193
Atea Pharmaceuticals
AVIR
$379M
| $206K | ﹤0.01% |
+61,639
| New | +$250K |
|
3194
Vince Holding Corp
VNCE
$81.8M
| $206K | ﹤0.01% |
29,708
+30
| +0.1% | +$216 |
|
3195
Biohaven
BHVN
$2.03B
| $204K | ﹤0.01% |
14,944
-4,142
| -22% | -$65.9K |
|
|
SLGC
3196
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $204K | ﹤0.01% |
+79,985
| New | +$229K |
|
3197
US Gold Corp
USAU
$215M
| $204K | ﹤0.01% |
36,498
| – | – |
|
|
KNTE
3198
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $203K | ﹤0.01% |
32,546
-5,852
| -15% | -$35.7K |
|
|
AENZ
3199
DELISTED
Aenza S.A.A.
AENZ
| $201K | ﹤0.01% |
79,408
| – | – |
|
3200
Praxis Precision Medicines
PRAX
$8.58B
| $200K | ﹤0.01% |
16,510
+8,691
| +111% | +$367K |
|
Similar funds
Dimensional Fund Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Dimensional Fund Advisors held 3,570 positions worth $297B, up 87,611% from $338M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q1 2023 filing shows 79 new, 2,112 increased, 1,113 reduced and 109 closed positions. Its largest new stake was GE HealthCare: 1,253,762 shares worth $103M. The largest sale was Walmart Inc, an estimated $320M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2023 buy was GE HealthCare: 1,253,762 shares worth $103M.
- Dimensional Fund Advisors added most to Apple in Q1 2023, an estimated $150M increase.
- Dimensional Fund Advisors's biggest Q1 2023 reduction was Walmart Inc, cutting an estimated $320M.
- Dimensional Fund Advisors fully exited Dimensional Emerging Markets Sustainability Core 1 ETF in Q1 2023, selling an estimated $11.3M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $297B portfolio in Q1 2023.
- Dimensional Fund Advisors opened 79 new positions and closed 109 in Q1 2023.
- Dimensional Fund Advisors's portfolio value rose 87,611% quarter-over-quarter to $297B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.